Navigation

Clariscan

side effects drug center clariscan (gadoterate meglumine injection) drug - patient side effects and images

  • Related Drugs
    Ablavar Dotarem Eovist Magnevist MultiHance Omniscan OptiMARK ProHance Pylarify
    • Clariscan Patient Information Including Side Effects

    Brand Names: Clariscan, Dotarem

    Generic Name: gadoterate meglumine

    What is gadoterate meglumine (Clariscan, Dotarem)?

    Gadoterate meglumine is a contrast agent that has magnetic properties. It is used in combination with magnetic resonance imaging (MRI) to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on the MRI.

    Gadoterate meglumine is used to help diagnose certain disorders of the brain and spine (central nervous system).

    Gadoterate meglumine may also be used for purposes not listed in this medication guide.

    What are the possible side effects of gadoterate meglumine (Clariscan, Dotarem)?

    Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

    Some side effects of gadoterate meglumine may occur up to several days after injection.

    Gadoterate meglumine can cause a life-threatening condition in people with advanced kidney disease. Call your doctor right away if you have any symptoms of this condition, such as:

    • burning, itching, swelling, scaling, and tightening or hardening of your skin;
    • muscle weakness;
    • joint stiffness in your arms, hands, legs, or feet;
    • deep bone pain in your ribs or your hips;
    • trouble moving; or
    • skin redness or discoloration.

    Also call your doctor at once if you have:

    • kidney problems--little or no urinating, painful or difficult urination, swelling in your feet or ankles, feeling tired or short of breath.

    Common side effects may include:

    • headache;
    • nausea;
    • rash; or
    • pain or cold feeling around the IV needle.

    This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    What is the most important information I should know about gadoterate meglumine (Clariscan, Dotarem)?

    Gadoterate meglumine can cause a life-threatening condition in people with advanced kidney disease. You should not receive this medication if you have kidney disease or if you are on dialysis.

    Clariscan Patient Information including How Should I Take

    What should I discuss with my healthcare provider before receiving gadoterate meglumine (Clariscan, Dotarem)?

    Gadoterate meglumine can cause a life-threatening condition in people with advanced kidney disease. You should not receive this medicine if you have kidney disease or if you are on dialysis.

    Gadoterate meglumine can stay in your body for months or years after you receive this medicine. It is not known whether this could cause any health problems in people whose kidneys work properly. Tell your doctor if you have had repeated scans with a contrast agent, and provide the date of your last scan.

    You should not receive gadoterate meglumine if you are allergic to it.

    Tell your doctor if you have ever had:

    It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant.

    It may not be safe to breast-feed shortly after receiving this medicine. Ask your doctor about any risk.

    How is gadoterate meglumine given (Clariscan, Dotarem)?

    Gadoterate meglumine is given as an infusion into a vein. A healthcare provider will give you this injection.

    Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when the medicine is injected.

    Your doctor or other healthcare provider may want to watch you for a short time after your test is over. This is to make sure you do not have any unwanted side effects or delayed reactions.

    Clariscan Patient Information including If I Miss a Dose

    What happens if I miss a dose (Clariscan, Dotarem)?

    Since gadoterate meglumine is used only during your MRI, you will not be on a dosing schedule.

    What happens if I overdose (Clariscan, Dotarem)?

    Since this medicine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

    What should I avoid after receiving gadoterate meglumine (Clariscan, Dotarem)?

    Follow your doctor's instructions about any restrictions on food, beverages, or activity.

    What other drugs will affect gadoterate meglumine (Clariscan, Dotarem)?

    Other drugs may affect gadoterate meglumine, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

    Where can I get more information (Clariscan, Dotarem)?

    Your doctor can provide more information about gadoterate meglumine.

    Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
    Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Copyright 1996-2021 Cerner Multum, Inc.